New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma.
Carlino MS, Kwan V, Miller DK, Saunders CA, Yip D, Nagrial AM, Tomlinson J, Grimmond SM, Scolyer RA, Kefford RF, Biankin AV, Long GV.
Carlino MS, et al. Among authors: yip d.
J Clin Oncol. 2015 Apr 10;33(11):e52-6. doi: 10.1200/JCO.2013.51.5783. Epub 2014 May 12.
J Clin Oncol. 2015.
PMID: 24821886
No abstract available.